- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Varicella zoster recombinant vaccine – November 2018
Varicella Zoster Virus Recombinant Vaccine: injection [1 vial] & adjuvant substance diluent [0.5 mL
Last updated
15 March 2019